These include Rybelsus (oral semaglutide) for type 2 diabetes, oral Wegovy (semaglutide) for chronic weight management, and Foundayo (orforglipron), a newer oral GLP-1 medication approved for obesity treatment
The mechanism is based on the carnitine pendulum (CPT1/translocase/CPT2), buffering of free CoA during exercise and the effect on post-exercise regeneration markers (Stephens et al
Finally, this study had a fairly short follow-up time, so it does not necessarily show how GLP-1RAs affect long-term depression risk
KPV may actually serve as an immune modulator, balancing over-active immune response rather than totally suppressing it
Modo d'uso: si consiglia di assumere fino a 2 confezioni al giorno, in relazione alla durata ed intensit della prestazione sportiva
Wegovy is FDA-approved for: Weight management in people with obesity or those who have overweight and a weight-related comorbidity like high blood pressure, type 2 diabetes, and dyslipidemia (unhealthy levels of cholesterol and fat in the blood) Reducing the risk of cardiovascular events in those with heart disease and obesity or overweight While the two medications share the same active ingredient, Wegovy is available at a higher maximum dose strength than Ozempic
